Your browser doesn't support javascript.
loading
Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives.
Iorfida, Monica; Mazza, Manuelita; Munzone, Elisabetta.
Affiliation
  • Iorfida M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, Italy.
  • Mazza M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, Italy.
  • Munzone E; Division of Medical Senology, European Institute of Oncology, IRCCS, Milano 20141, Italy.
Breast Cancer (Dove Med Press) ; 12: 45-56, 2020.
Article in En | MEDLINE | ID: mdl-32256106
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Breast Cancer (Dove Med Press) Year: 2020 Document type: Article Affiliation country: Italia Country of publication: Nueva Zelanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Breast Cancer (Dove Med Press) Year: 2020 Document type: Article Affiliation country: Italia Country of publication: Nueva Zelanda